IGF-1R drugs travel from cancer cradle to Graves’

One of the most intensively investigated molecular targets in oncology proves its therapeutic worth for thyroid eye disease.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dolgin, E. IGF-1R drugs travel from cancer cradle to Graves’. Nat Biotechnol 38, 385–388 (2020). https://doi.org/10.1038/s41587-020-0481-8

Download citation